Clinical Trial Update: CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial (CHIO3) is evaluating chemotherapy combined with an immune checkpoint inhibitor for operable stage IIIA/IIIB non-small cell lung cancer; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Alliance Foundation Trials, LLC. | Conditions: Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING